1D·

Bristol Myers Dividend and Alleged Merger with AstraZeneca🦠💊💉

Rumors of an alleged merger between $BMY (-1,97%) and $AZN (-0,58%)

Both companies are in the oncology industry .

A merger of the two companies would create a company with a market value of $400 billion . This would also make it the 4th largest pharmaceutical manufacturer.

Bristol Myers is facing impending patent expirations for blockbuster drugs such as Eliquis and Opdivo. A merger would significantly strengthen the pipeline of cancer therapies strengthen.

Skepticism at Astrashareholders: Many analysts are wondering whether AstraZeneca can handle this huge and complex undertaking at all, both financially and strategically.

At the moment, nothing is set in stone , but discussions are underway.

What is your opinion of Bristol and AstraZeneca shareholders?

03.08

Bristol-Myers Squibb

Recebido x78 Dividendos em US$ 0,63

US$ 49,14

6 Comentários

Seventrader@7Trader

21H

It's doubtful whether such a large merger would even receive approval from the FTC, the European Commission, and the UK's CMA.
It's an intriguing prospect, but I can't quite picture it happening right now.

•

Poor Dad@PoorDad

21H

@7Trader I can't really picture it either. But the stock market is full of surprises.

••

Seventrader@7Trader

20H

@PoorDad As for $BMY 's promotions, I'm not sure yet if I'd be happy about them—what do you think? In theory, would you hold onto your shares in the event of a merger, or would you sell them off at some point?

••

Poor Dad@PoorDad

10H

@7Trader Since I'm already very bullish on healthcare anyway, I do think I'd hold onto a giant like that... at least until it makes sense to maybe trim the position a bit. What about you?

••

Seventrader@7Trader

@PoorDad I'll probably keep holding on.

•

CashDividendGamer@CashDividendGamer

21H

Oncology. And a merger could be interesting if it happens. We'll have to wait and see.

••